|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
SCIDIR_on1190859379 |
| 003 |
OCoLC |
| 005 |
20231120010507.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
200828s2020 ne o 001 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|e pn
|c YDX
|d OPELS
|d EBLCP
|d UKAHL
|d UKMGB
|d OCLCF
|d OCLCO
|d OCLCQ
|d K6U
|d OCLCQ
|d OCLCO
|
| 015 |
|
|
|a GBC0B7107
|2 bnb
|
| 016 |
7 |
|
|a 019886921
|2 Uk
|
| 020 |
|
|
|a 9780128178393
|q (electronic bk.)
|
| 020 |
|
|
|a 0128178396
|q (electronic bk.)
|
| 020 |
|
|
|z 9780128178386
|
| 020 |
|
|
|z 0128178388
|
| 035 |
|
|
|a (OCoLC)1190859379
|
| 050 |
|
4 |
|a TA418.9.N35
|
| 082 |
0 |
4 |
|a 620.1/15
|2 23
|
| 245 |
0 |
0 |
|a Nanomaterials for theranostics and tissue engineering :
|b techniques, trends and applications /
|c edited by Filippo Rossi and Alberto Rainer.
|
| 260 |
|
|
|a Amsterdam :
|b Elsevier,
|c 2020.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Micro and Nano Technologies
|
| 500 |
|
|
|a Includes index.
|
| 505 |
0 |
|
|a Front Cover -- Nanomaterials for Theranostics and Tissue Engineering -- Copyright Page -- Contents -- List of contributors -- Introduction -- 1 Polymeric nanoparticles for controlled drug delivery -- 1.1 General concepts and synthetic strategies -- 1.2 Polymer nanoparticles for controlled drug delivery -- 1.2.1 Stimuli-responsive polymer nanoparticles -- 1.3 The long road from the bench to the clinic -- 1.4 Conclusions -- References -- 2 Extracellular vesicles in regenerative medicine -- 2.1 Introduction -- 2.2 Cell-based therapies -- 2.3 Tissue engineering -- 2.4 Cell-free therapies
|
| 505 |
8 |
|
|a 2.4.1 Soluble factors -- 2.4.2 Biogenic and synthetic nanoparticles -- 2.5 Extracellular vesicles in a nutshell -- 2.5.1 Extracellular vesicle biological and physicochemical properties -- 2.5.2 Extracellular vesicle separation and characterization -- 2.5.3 Medical translation of extracellular vesicles -- 2.6 Regenerative properties of extracellular vesicles -- 2.6.1 Why extracellular vesicles? -- 2.6.2 Preclinical studies -- 2.6.3 Clinical studies -- 2.6.4 Limits of extracellular vesicle applications in clinical treatments -- 2.7 Conclusions -- Acknowledgments -- References
|
| 505 |
8 |
|
|a 3 Novel strategies to improve delivery performances -- 3.1 Introduction -- 3.2 Functionalization strategies: the rationale -- 3.2.1 Chemical routes -- 3.2.1.1 Esterification and modification of active ester -- 3.2.1.2 Click chemistry -- 3.2.1.3 Other chemical cross-linking strategies -- 3.2.2 Physical routes -- 3.3 Applications in tissue engineering -- 3.3.1 The cell membranes barrier -- 3.3.2 The tumor environment -- 3.3.3 The blood-brain barrier -- 3.4 Applications in theranostics -- 3.5 Conclusions -- References -- 4 HR-MAS NMR Spectroscopy: novel technologies to measure delivery performance
|
| 505 |
8 |
|
|a 4.1 Introduction -- 4.2 High-resolution magic angle spinning nuclear magnetic resonance -- 4.2.1 Theory -- 4.2.2 Experimental setup -- 4.2.3 Example HR-MAS resolution enhancement in hydrogel polymers and swollen polymers -- 4.3 Pulse field gradient HR-MAS nuclear magnetic resonance spectroscopy -- 4.3.1 Translational motion in isotropic systems -- 4.3.2 Restricted and anisotropic motion -- 4.4 Applications in drug delivery -- 4.4.1 Cyclodextrin nanosponges polymers -- 4.4.2 Agarose-carbomer copolymers hydrogels -- 4.5 Final remarks -- References
|
| 505 |
8 |
|
|a 5 The role of first principles mathematical modeling in the nanomedicine field -- 5.1 The new challenges introduced by nanomedicine -- 5.2 Modeling approaches -- 5.2.1 An introduction to molecular modeling -- 5.2.2 Molecular dynamics -- 5.2.3 Coarse-grained simulations -- 5.2.4 Enhanced sampling methods -- 5.2.5 Macroscale models -- 5.3 Applications of mathematical modeling in the nanomedicine field -- 5.3.1 Biomolecular corona -- 5.3.2 Targeting and cellular uptake -- 5.3.3 Nanoparticle distribution and drug delivery -- 5.4 Conclusions -- References
|
| 650 |
|
0 |
|a Nanostructured materials.
|
| 650 |
|
0 |
|a Nanomedicine.
|
| 650 |
|
0 |
|a Tissue engineering.
|
| 650 |
|
2 |
|a Nanostructures
|0 (DNLM)D049329
|
| 650 |
|
2 |
|a Tissue Engineering
|0 (DNLM)D023822
|
| 650 |
|
2 |
|a Nanomedicine
|0 (DNLM)D050997
|
| 650 |
|
6 |
|a Nanomat�eriaux.
|0 (CaQQLa)201-0258061
|
| 650 |
|
6 |
|a G�enie tissulaire.
|0 (CaQQLa)201-0392445
|
| 650 |
|
6 |
|a Nanom�edecine.
|0 (CaQQLa)201-0448752
|
| 650 |
|
7 |
|a Nanomedicine
|2 fast
|0 (OCoLC)fst01744350
|
| 650 |
|
7 |
|a Nanostructured materials
|2 fast
|0 (OCoLC)fst01032630
|
| 650 |
|
7 |
|a Tissue engineering
|2 fast
|0 (OCoLC)fst01151484
|
| 700 |
1 |
|
|a Rossi, Filippo.
|
| 700 |
1 |
|
|a Rainer, Alberto.
|
| 776 |
0 |
8 |
|i Print version:
|t Nanomaterials for theranostics and tissue engineering.
|d Amsterdam : Elsevier, 2020
|z 0128178388
|z 9780128178386
|w (OCoLC)1122909371
|
| 830 |
|
0 |
|a Micro & nano technologies.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128178386
|z Texto completo
|
